ANXA6 and psoriasis: Formal external validation is limited by the requirement for additional independent, population-matched GWAS data for AD and psoriasis, but data available from RNA sequencing and microarray analyses provide some support for the differential expression of ANXA6/TNIP1 and PRKRA in AD and psoriasis, relative to normal or uninvolved skin.